BR112012003209A2 - composições e métodos para tratar infecção fúngica da unha - Google Patents

composições e métodos para tratar infecção fúngica da unha

Info

Publication number
BR112012003209A2
BR112012003209A2 BR112012003209A BR112012003209A BR112012003209A2 BR 112012003209 A2 BR112012003209 A2 BR 112012003209A2 BR 112012003209 A BR112012003209 A BR 112012003209A BR 112012003209 A BR112012003209 A BR 112012003209A BR 112012003209 A2 BR112012003209 A2 BR 112012003209A2
Authority
BR
Brazil
Prior art keywords
compositions
methods
treating fungal
fungal nail
nail infection
Prior art date
Application number
BR112012003209A
Other languages
English (en)
Inventor
Äke Lindahl
Original Assignee
Moberg Derma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moberg Derma Ab filed Critical Moberg Derma Ab
Publication of BR112012003209A2 publication Critical patent/BR112012003209A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BR112012003209A 2009-08-13 2010-08-13 composições e métodos para tratar infecção fúngica da unha BR112012003209A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23355709P 2009-08-13 2009-08-13
PCT/SE2010/050886 WO2011019317A1 (en) 2009-08-13 2010-08-13 Compositions and methods for treating fungal infection of the nail

Publications (1)

Publication Number Publication Date
BR112012003209A2 true BR112012003209A2 (pt) 2016-03-01

Family

ID=43586315

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012003209A BR112012003209A2 (pt) 2009-08-13 2010-08-13 composições e métodos para tratar infecção fúngica da unha

Country Status (14)

Country Link
US (1) US20120129942A1 (pt)
EP (1) EP2464334A4 (pt)
JP (1) JP2013501780A (pt)
KR (1) KR20120038444A (pt)
CN (1) CN102470102A (pt)
AU (1) AU2010283031A1 (pt)
BR (1) BR112012003209A2 (pt)
CA (1) CA2764236A1 (pt)
IL (1) IL217845A0 (pt)
MX (1) MX2012001766A (pt)
RU (1) RU2011150901A (pt)
SG (1) SG177750A1 (pt)
WO (1) WO2011019317A1 (pt)
ZA (1) ZA201108753B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2478159A (en) * 2010-02-26 2011-08-31 Lrc Products Composition for the treatment of fungal nail infection
WO2012110430A1 (en) * 2011-02-10 2012-08-23 Moberg Derma Ab Novel composition for topical use on a nail
AU2012215383B2 (en) * 2011-02-11 2016-06-09 Moberg Pharma Ab Novel antifungal composition
WO2014140507A1 (en) 2013-03-15 2014-09-18 Moberg Pharma Ab Pharmaceutical composition for the treatment of fungal infections
GB201416727D0 (en) * 2014-09-22 2014-11-05 Novabiotics Ltd Use
US10543276B2 (en) 2016-08-08 2020-01-28 Marlinz Pharma, LLC Topical compositions
US10206962B1 (en) 2016-08-08 2019-02-19 Marlinz Pharma, LLC Method for treating fungal infections in nails
EP3897604A4 (en) * 2018-12-19 2022-08-17 Marlinz Pharma, LLC TOPICAL COMPOSITIONS
KR102597564B1 (ko) * 2023-03-03 2023-11-03 장병모 조갑 및 피부 백선의 예방 또는 치료용 약학적 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4212105A1 (de) * 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
KR20000045198A (ko) * 1998-12-30 2000-07-15 김수지 항진균성 손톱 와니스
US7074392B1 (en) * 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US8486426B2 (en) * 2002-07-29 2013-07-16 Kimberly-Clark Worldwide, Inc. Methods and compositions for treatment of dermal conditions
PT1545619E (pt) * 2002-09-05 2008-02-28 Galderma Sa Solução destinada a uma aplicação sobre as unhas
EP2457560A1 (en) * 2006-06-14 2012-05-30 Dr Reddy's Laboratories Limited Topical compositions
EP2124878B1 (en) * 2007-02-05 2015-09-02 Biophile Corporation, Ltd Increased effectiveness of allylamine drug compounds
US20090175810A1 (en) * 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail

Also Published As

Publication number Publication date
CA2764236A1 (en) 2011-02-17
RU2011150901A (ru) 2013-09-20
SG177750A1 (en) 2012-03-29
EP2464334A1 (en) 2012-06-20
ZA201108753B (en) 2012-08-29
IL217845A0 (en) 2012-03-29
EP2464334A4 (en) 2014-03-26
KR20120038444A (ko) 2012-04-23
CN102470102A (zh) 2012-05-23
WO2011019317A1 (en) 2011-02-17
JP2013501780A (ja) 2013-01-17
MX2012001766A (es) 2012-03-07
AU2010283031A1 (en) 2012-01-19
US20120129942A1 (en) 2012-05-24

Similar Documents

Publication Publication Date Title
BRPI0919238A2 (pt) métodos e composições para o tratamento de câncer
BR112012004979A2 (pt) composições para o tratamento de semente e métodos
BRPI1007972A2 (pt) composições de combinação e métodos para o tratamento de câncer
BRPI1011325A2 (pt) composições e métodos para o tratamento de inflamação
BRPI0908854A2 (pt) composições e métodos para o tratamento de tumor de origem hematopoética
BR112013023027A2 (pt) composições e métodos para esmaltes de unha curáveis por uv
BR112013010725A2 (pt) método, e, composição
BRPI0909164A2 (pt) método e composições para o tratamento de câncer
BRPI0921959A2 (pt) métodos e composições para remoção de tatuagem
PL2356462T3 (pl) Kompozycje anty-CXCR1 oraz sposoby
ITTO20110641A1 (it) Composizioni farmaceutiche e metodi di trattamento
FI20096058A0 (fi) Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
PT2512502T (pt) Métodos e composições para supressão de tumores
BRPI1007477A2 (pt) método, e, composição de tratamento de poço
BRPI1008566A2 (pt) métodos e composições para o diagnóstico e tratamento de câncer
PT2632452T (pt) Compostos e composições para o tratamento do cancro
BRPI1007667A2 (pt) condicionador capilar e composição
BRPI1008326A2 (pt) Composições e métodos para controlar nanatódeos
BRPI0822349A2 (pt) composições e métodos para tratar doenças lisossômicas
BRPI1007600A2 (pt) composições e métodos para tratamento de doenças cardiovasculares
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
BRPI1013927A2 (pt) métodos e composições para o tratamento de lúpus
BR112013006232A2 (pt) processo de tratamento cosmético, composto e composição cosmética
BRPI1014488A2 (pt) composições adequadas para o tratamento tópico de infecções fúngicas da pele e das unhas
IL217845A0 (en) Compositions and methods for treating fungal infection of the nail

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2377 DE 26-07-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]